Table 2.
In vivo/ex vivo study: Experimental protocol and sampling.
| Total Number of Rats: 63 | Saline Injection CONTROL (CTR): 17 | STZ Injection DIABETIC (D): 46 | |
|---|---|---|---|
| Three weeks after injection | CTR: 15 | UNTREATED | RSV TREATED |
| D3: 16 | D3_RSV: 14 | ||
| Experimental procedures | |||
| Cell mechanics | CTR: 10 | D3: 8 | D3_RSV: 6 |
| Immunohistochemistry | CTR: 3 | D3: 4 | D3_RSV: 4 |
| Western Blot | CTR: 2 | D3: 4 | D3_RSV: 4 |
| Eight weeks after injection | CTR: 2 | D8: 8 | D8_RSV: 8 |
| Experimental procedures | |||
| Immunohistochemistry (M1-M2) | CTR: 2 | D8: 5 | D8_RSV: 5 |
| TEM | - | D8: 3 | D8_RSV: 3 |
D3 and D3-RSV: untreated and resveratrol (RSV) treated group, after 3 weeks of hyperglycemia; D8 and D8-RSV: untreated and RSV- treated group, after 8 weeks of hyperglycemia.